Detalhe da pesquisa
1.
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients.
Anal Chem;
96(18): 6914-6921, 2024 May 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38655666
2.
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.
JAMA;
331(17): 1452-1459, 2024 05 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38581254
3.
Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial.
J Urol;
210(4): 630-638, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37384841
4.
Predictive value of kallikrein forms and ß-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy.
World J Urol;
41(6): 1489-1495, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37209144
5.
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy.
Proc Natl Acad Sci U S A;
117(26): 15172-15181, 2020 06 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32532924
6.
Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB.
Hum Mol Genet;
29(10): 1581-1591, 2020 06 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32065238
7.
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence.
Br J Cancer;
126(7): 1004-1009, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34903844
8.
Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial.
J Urol;
208(2): 292-300, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35422134
9.
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study.
BJU Int;
130(2): 193-199, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34958531
10.
Two-Step Acoustophoresis Separation of Live Tumor Cells from Whole Blood.
Anal Chem;
93(51): 17076-17085, 2021 12 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34913344
11.
Prospective validation of microseminoprotein-ß added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort.
BJU Int;
128(2): 218-224, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33306251
12.
Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels.
Prostate;
80(16): 1405-1412, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32914890
13.
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men.
Prostate;
80(1): 51-56, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31603253
14.
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy.
Br J Cancer;
123(4): 604-609, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32467601
15.
Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years.
J Urol;
204(2): 281-288, 2020 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32125228
16.
Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate.
J Urol;
204(1): 71-78, 2020 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32068491
17.
Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.
Prostate;
79(10): 1079-1089, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31104332
18.
Eight Misconceptions about Prostate-Specific Antigen.
Clin Chem;
70(1): 13-16, 2024 01 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38175588
19.
Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function.
Clin Chem;
65(1): e1-e9, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30538125
20.
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases.
Br J Cancer;
119(3): 347-356, 2018 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29988112